US 7,125,962 B2 · Anti-Pro268 antibodies

Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims5

Dependent claims

An isolated antibody that specifically binds to the polypeptide of SEQ ID NO:30.

Dependencies are inferred from the claim text.

Facts

Application

10/174,576Filed 18 Jun 2002 · continuation

Priority

31 Oct 1997

Published

US 2003/0032104 A113 Feb 2003

Granted

24 Oct 2006

Term ends

Not estimatedThe source records don’t support an estimate.

Classification56 codes

C07K 14/47
From vertebrates: from mammals
C07H 21/04
Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of…: with…
C07K 1/00
General methods for the preparation of peptides , i.e. processes for the
C07K 14/00
Peptides having more than 20 amino acids

Family

Application60/063,870Us provisional application · filed 31 Oct 1997

PCT/US98/19330Parent of this continuation-in-part · filed 16 Sep 1998

PCT/US01/06520Parent of this continuation · filed 28 Feb 2001

Application10/052,586Parent of this continuation · filed 15 Jan 2002

US 2003/0032104 A1Pre-grant publication · published 13 Feb 2003

Application09/380,139Parent of this continuation-in-part

PCT/US01/06520Parent of this continuation-in-part

US 2002/0127584 A1Published application

US 7,125,962 B2This patent

From the US filing history. Foreign family members aren’t listed.

Anti-Pro268 antibodies

Life of this patent

Anti-Pro268 antibodies

Life of this patent

Abstract

Claims5